ATE261990T1 - Entzündungshemmende peptide des c-reaktiven proteins - Google Patents

Entzündungshemmende peptide des c-reaktiven proteins

Info

Publication number
ATE261990T1
ATE261990T1 AT98929610T AT98929610T ATE261990T1 AT E261990 T1 ATE261990 T1 AT E261990T1 AT 98929610 T AT98929610 T AT 98929610T AT 98929610 T AT98929610 T AT 98929610T AT E261990 T1 ATE261990 T1 AT E261990T1
Authority
AT
Austria
Prior art keywords
sub
ile
reactive protein
human
terminal
Prior art date
Application number
AT98929610T
Other languages
English (en)
Inventor
Matityahu Fridkin
Eran J Yavin
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE261990T1 publication Critical patent/ATE261990T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4737—C-reactive protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT98929610T 1997-06-29 1998-06-29 Entzündungshemmende peptide des c-reaktiven proteins ATE261990T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL12119197A IL121191A0 (en) 1997-06-29 1997-06-29 Synthetic peptides and pharmaceutical compositions comprising them
PCT/IL1998/000302 WO1999000418A1 (en) 1997-06-29 1998-06-29 Anti-inflammatory peptides derived from c-reactive protein

Publications (1)

Publication Number Publication Date
ATE261990T1 true ATE261990T1 (de) 2004-04-15

Family

ID=11070323

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98929610T ATE261990T1 (de) 1997-06-29 1998-06-29 Entzündungshemmende peptide des c-reaktiven proteins

Country Status (8)

Country Link
US (2) US6528618B1 (de)
EP (1) EP0996633B1 (de)
AT (1) ATE261990T1 (de)
AU (1) AU7929198A (de)
DE (1) DE69822467T2 (de)
ES (1) ES2218836T3 (de)
IL (2) IL121191A0 (de)
WO (1) WO1999000418A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2391651A1 (en) * 1999-11-19 2001-05-25 Eli Lilly And Company Protein c derivatives
CN1213062C (zh) 2001-07-13 2005-08-03 一泰医药研究(深圳)有限公司 序列号13的生物活性肽
US6964950B2 (en) 2001-07-25 2005-11-15 Isis Pharmaceuticals, Inc. Antisense modulation of C-reactive protein expression
US7425545B2 (en) 2001-07-25 2008-09-16 Isis Pharmaceuticals, Inc. Modulation of C-reactive protein expression
BR0213293A (pt) 2001-10-15 2004-12-21 Chiron Corp Uso de tfpi ou de um análogo de tfpi no tratamento de septicemia
FI20012082A0 (fi) * 2001-10-26 2001-10-26 Paeivi Liesi Biologisesti aktiiviset peptidit hermovauroiden korjaamiseksi
WO2005056044A1 (en) * 2003-10-23 2005-06-23 Terry Du Clos Use of c-reactive protein to treat immune complex-mediated renal disease
KR101399175B1 (ko) * 2006-07-21 2014-06-19 푼다싸웅 지 앙빠루 아 뻬스끼자 두 에스따두 지 싸웅 파울루 - 에피아뻬에에씨뻬 항염증성 및 항알레르기성 시클릭 펩티드
SG10201503351RA (en) 2010-01-19 2015-06-29 Harvard College Engineered Opsonin for Pathogen Detection and Treatment
CA3149018A1 (en) 2011-07-18 2013-01-24 President And Fellows Of Harvard College Engineered microbe-targeting molecules and uses thereof
US10551379B2 (en) 2013-03-15 2020-02-04 President And Fellows Of Harvard College Methods and compositions for improving detection and/or capture of a target entity
EP3848045A1 (de) 2013-05-21 2021-07-14 President and Fellows of Harvard College Manipulierte hämbindende zusammensetzungen und verwendungen davon
US10513546B2 (en) 2013-12-18 2019-12-24 President And Fellows Of Harvard College CRP capture/detection of gram positive bacteria
US10435457B2 (en) 2015-08-06 2019-10-08 President And Fellows Of Harvard College Microbe-binding molecules and uses thereof

Also Published As

Publication number Publication date
WO1999000418A1 (en) 1999-01-07
DE69822467D1 (de) 2004-04-22
US6528618B1 (en) 2003-03-04
US7182945B2 (en) 2007-02-27
DE69822467T2 (de) 2005-03-24
IL133769A (en) 2006-06-11
EP0996633A1 (de) 2000-05-03
EP0996633B1 (de) 2004-03-17
AU7929198A (en) 1999-01-19
US20030152564A1 (en) 2003-08-14
ES2218836T3 (es) 2004-11-16
IL121191A0 (en) 1997-11-20

Similar Documents

Publication Publication Date Title
DE69822467D1 (de) Entzündungshemmende peptide des c-reaktiven proteins
Wilkinson Troponin C from rabbit slow skeletal and cardiac muscle is the product of a single gene
TR199701718T1 (xx) Somatostatin Peptidler.
AU4162400A (en) Derivatives of the b or z domain from staphylococcal protein a (spa) interactingwith at least one domain of human factor viii
GB9108652D0 (en) Immunoreactive compounds
ATE110414T1 (de) System zur bearbeitung von hefe, welches eine zur bearbeitungsstelle benachbarte negativ geladene aminosäure beeinhaltet.
DK323587D0 (da) Protein
WO2002026935A3 (en) TGF-β INHIBITORS AND METHODS
EA200000652A1 (ru) Кристаллы глюкагоноподобного пептида 1
WO2004014940A3 (en) PEPTIDES AS SOLUBILIZING EXCIPIENTS FOR TRANSFORMING GROWTH FACTOR ß PROTEINS
Travis et al. The amino acid sequence of ferredoxin from the sulfate reducing bacterium, Desulfovibrio gigas
DE3770915D1 (de) Menschliches apolipoprotein a1 sowie dessen variante, exprimiert in escherichia coli.
NO921946L (no) Proteinkomplekser med faktor viii:c-aktivitet, samt fremstilling derav
AU2001231881A1 (en) Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and theuse thereof in the synthesis of synthetic proteins and polypeptides
CA2334941A1 (en) Tnf-derived peptides for use in treating oedema
ATE118349T1 (de) Als therapeutika geeignete peptide.
DE69735242D1 (de) N-terminal verlängerte proteine exprimiert in hefe
PT833917E (pt) Moleculas polipeptidicas do estadio pre-eritrocitario do paludismo
WO1999002708A8 (en) Fusion proteins comprising sequences derived from bovine if1 atpase inhibitor protein
ATE294816T1 (de) Neue, physiologisch aktive peptide und ihre verwendung.
DE60313970D1 (de) Lineare kationische peptide mit fungizider wirksamkeit
DE69315849D1 (de) Peptide als lungensurfactant und therapeutisch wirksame mischungen
HUP0203504A2 (hu) Immunterápiás alkalmazásra szolgáló módosított peptidek és peptid-mimetikumok
NZ335136A (en) Isolated peptides which complex with hla-cw*16 molecules, and uses thereof
DE69737561D1 (de) Klonierte rezeptoren des glukagon-ähnlichen peptids-2

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0996633

Country of ref document: EP

REN Ceased due to non-payment of the annual fee